Results, complications, and dosimetric and surgical considerations. Rarely, surgery may be combined with the above. Boronow RC, Hickman BT, Reagan MT, et al. Results, complications, and dosimetric and surgical considerations. Squamous cell carcinoma Patients should be considered candidates for one of the ongoing clinical trials to improve therapeutic results.
Standard treatment is inadequate.
Adenocarcinoma Patients should be considered candidates for one of the ongoing clinical trials to improve therapeutic results. In a large series only five of fifty patients with recurrence were salvaged by surgery or radiation therapy. Most recurrences are in the first 2 years after treatment. In centrally recurrent vaginal cancers, some patients may be candidates for pelvic exenteration or irradiation. Clinical trials are also appropriate and should be considered.